Journal of Korean Neurosurgical Society

  • 제52권3호
  • /
  • Pages.193-199
  • /
  • 2012
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases

  • Jung, Jong-Myung (Department of Neurosurgery, Seoul National University College of Medicine) ;
  • Kim, Sohee (Cancer Biostatistics Branch, National Cancer Center) ;
  • Joo, Jungnam (Cancer Biostatistics Branch, National Cancer Center) ;
  • Shin, Kyung Hwan (Department of Radiation Oncology, National Cancer Center) ;
  • Gwak, Ho-Shin (Neuro-Oncology Clinic, National Cancer Center) ;
  • Lee, Seung Hoon (Neuro-Oncology Clinic, National Cancer Center)
  • 투고 : 2012.01.10
  • 심사 : 2012.09.17
  • 발행 : 2012.09.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : The objective of study is to evaluate the incidence of leptomeningeal carcinomatosis (LMC) in breast cancer patients with parenchymal brain metastases (PBM) and clinical risk factors for the development of LMC. Methods : We retrospectively analyzed 27 patients who had undergone surgical resection (SR) and 156 patients with whole brain radiation therapy (WBRT) as an initial treatment for their PBM from breast cancer in our institution and compared the difference of incidence of LMC according to clinical factors. The diagnosis of LMC was made by cerebrospinal fluid cytology and/or magnetic resonance imaging. Results : A total of 27 patients (14%) in the study population developed LMC at a median of 6.0 months (range, 1.0-50). Ten of 27 patients (37%) developed LMC after SR, whereas 17 of 156 (11%) patients who received WBRT were diagnosed with LMC after the index procedure. The incidence of LMC was significantly higher in the SR group compared with the WBRT group and the hazard ratio was 2.95 (95% confidence interval; 1.33-6.54, p<0.01). Three additional factors were identified in the multivariable analysis : the younger age group (<40 years old), the progressing systemic disease showed significantly increased incidence of LMC, whereas the adjuvant chemotherapy reduce the incidence. Conclusion : There is an increased risk of LMC after SR for PBM from breast cancer compared with WBRT. The young age (<40) and systemic burden of cancer in terms of progressing systemic disease without adjuvant chemotherapy could be additional risk factors for the development of LMC.

키워드

참고문헌

  1. Ahn JH, Lee SH, Kim S, Joo J, Yoo H, Lee SH, et al. : Risk for leptomeningeal seeding after resection for brain metastases : implication of tumor location with mode of resection. J Neurosurg 116 : 984-993, 2012 https://doi.org/10.3171/2012.1.JNS111560
  2. Bae JS, Yang SH, Yoon WS, Kang SG, Hong YK, Jeun SS : The clinical features of spinal leptomeningeal dissemination from malignant gliomas. J Korean Neurosurg Soc 49 : 334-338, 2011 https://doi.org/10.3340/jkns.2011.49.6.334
  3. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE : Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22 : 2865-2872, 2004 https://doi.org/10.1200/JCO.2004.12.149
  4. Beadle BM, Woodward WA, Buchholz TA : The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21 : 26-34, 2011 https://doi.org/10.1016/j.semradonc.2010.09.001
  5. Chamberlain MC : Leptomeningeal metastasis. Curr Opin Oncol 22 : 627-635, 2010 https://doi.org/10.1097/CCO.0b013e32833de986
  6. Cheng X, Hung MC : Breast cancer brain metastases. Cancer Metastasis Rev 26 : 635-643, 2007 https://doi.org/10.1007/s10555-007-9083-x
  7. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, et al. : Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131 : 1061-1066, 2012 https://doi.org/10.1007/s10549-011-1872-9
  8. DeAngelis LM : Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 38 : 245-252, 1998 https://doi.org/10.1023/A:1005956925637
  9. DeAngelis LM, Mandell LR, Thaler HT, Kimmel DW, Galicich JH, Fuks Z, et al. : The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 24 : 798-805, 1989 https://doi.org/10.1227/00006123-198906000-00002
  10. Dosoretz DE, Blitzer PH, Russell AH, Wang CC : Management of solitary metastasis to the brain : the role of elective brain irradiation following complete surgical resection. Int J Radiat Oncol Biol Phys 6 : 1727- 1730, 1980 https://doi.org/10.1016/0360-3016(80)90260-6
  11. Fortner JG : Inadvertent spread of cancer at surgery. J Surg Oncol 53 : 191-196, 1993 https://doi.org/10.1002/jso.2930530313
  12. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G : Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22 : 1-6, v, 2011 https://doi.org/10.1016/j.nec.2010.08.007
  13. Freilich RJ, Krol G, DeAngelis LM : Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38 : 51-57, 1995 https://doi.org/10.1002/ana.410380111
  14. Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, et al. : Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21 : 2183-2187, 2010 https://doi.org/10.1093/annonc/mdq232
  15. Glass JP, Melamed M, Chernik NL, Posner JB : Malignant cells in cerebrospinal fluid (CSF) : the meaning of a positive CSF cytology. Neurology 29 : 1369-1375, 1979 https://doi.org/10.1212/WNL.29.10.1369
  16. Grabb PA, Albright AL, Pang D : Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30 : 64-71, 1992 https://doi.org/10.1227/00006123-199201000-00012
  17. Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim TM, et al. : Clinical outcome of central nervous system metastases from breast cancer : differences in survival depending on systemic treatment. J Neurooncol 106 : 303-313, 2012 https://doi.org/10.1007/s11060-011-0664-8
  18. Lee S, Ahn HK, Park YH, Nam do H, Lee JI, Park W, et al. : Leptomeningeal metastases from breast cancer : intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat 129 : 809-817, 2011 https://doi.org/10.1007/s10549-011-1682-0
  19. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP : Sites of distant recurrence and clinical outcomes in patients with metastatic triplenegative breast cancer : high incidence of central nervous system metastases. Cancer 113 : 2638-2645, 2008 https://doi.org/10.1002/cncr.23930
  20. Lin NU, Winer EP : Brain metastases : the HER2 paradigm. Clin Cancer Res 13 : 1648-1655, 2007 https://doi.org/10.1158/1078-0432.CCR-06-2478
  21. Mahajan A, Borden J, Tsai JS : Carcinomatous meningitis : are surgeryand gamma knife radiosurgery treatment risk factors? J Neurosurg 97 : 441-444, 2002 https://doi.org/10.3171/jns.2002.97.2.0441
  22. Mayo WJ : Grafting and traumatic dissemination of carcinoma in the course of operations for malignant disease. JAMA 60 : 512-513, 1913 https://doi.org/10.1001/jama.1913.04340070024009
  23. Mirimanoff RO, Choi NC : Intradural spinal metastases in patients with posterior fossa brain metastases from various primary cancers. Oncology 44 : 232-236, 1987 https://doi.org/10.1159/000226484
  24. Mirimanoff RO, Choi NC : The risk of intradural spinal metastases in patients with brain metastases from bronchogenic carcinomas. Int J Radiat Oncol Biol Phys 12 : 2131-2136, 1986 https://doi.org/10.1016/0360-3016(86)90012-X
  25. Norris LK, Grossman SA, Olivi A : Neoplastic meningitis following surgical resection of isolated cerebellar metastasis : a potentially preventable complication. J Neurooncol 32 : 215-223, 1997 https://doi.org/10.1023/A:1005723801479
  26. Pace A, Fabi A : Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60 : 194-200, 2006 https://doi.org/10.1016/j.critrevonc.2006.06.013
  27. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. : A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 : 494-500, 1990 https://doi.org/10.1056/NEJM199002223220802
  28. Pavlidis N : The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol 15 Suppl 4 : iv285-iv291, 2004 https://doi.org/10.1093/annonc/mdh941
  29. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, et al. : Carcinomatous leptomeningitis in small cell lung cancer : a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore) 61 : 45-53, 1982 https://doi.org/10.1097/00005792-198201000-00005
  30. Seute T, Leffers P, ten Velde GP, Twijnstra A : Leptomeningeal metastases from small cell lung carcinoma. Cancer 104 : 1700-1705, 2005 https://doi.org/10.1002/cncr.21322
  31. Siomin VE, Vogelbaum MA, Kanner AA, Lee SY, Suh JH, Barnett GH : Posterior fossa metastases : risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. J Neurooncol 67 : 115-121, 2004 https://doi.org/10.1023/B:NEON.0000021785.00660.2b
  32. Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD : Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 108 : 248-257, 2008 https://doi.org/10.3171/JNS/2008/108/2/0248
  33. Suki D, Hatiboglu MA, Patel AJ, Weinberg JS, Groves MD, Mahajan A, et al. : Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 64 : 664-674; discussion 674-676, 2009 https://doi.org/10.1227/01.NEU.0000341535.53720.3E
  34. Umpleby HC, Williamson RC : Anastomotic recurrence in large bowel cancer. Br J Surg 74 : 873-878, 1987 https://doi.org/10.1002/bjs.1800741003
  35. van der Ree TC, Dippel DW, Avezaat CJ, Sillevis Smitt PA, Vecht CJ, van den Bent MJ : Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatry 66 : 225-227, 1999 https://doi.org/10.1136/jnnp.66.2.225
  36. Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, et al. : Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93 : 205-212, 2009 https://doi.org/10.1007/s11060-008-9758-3
  37. Wasserstrom WR, Glass JP, Posner JB : Diagnosis and treatment of leptomeningeal metastases from solid tumors : experience with 90 patients. Cancer 49 : 759-772, 1982 https://doi.org/10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7
  38. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR : Meningeal carcinomatosis in breast cancer. Cancer 42 : 283-286, 1978 https://doi.org/10.1002/1097-0142(197807)42:1<283::AID-CNCR2820420142>3.0.CO;2-#
  39. Yildirim E, Dalgic T, Berberoğlu U : Prognostic significance of young age in breast cancer. J Surg Oncol 74 : 267-272, 2000 https://doi.org/10.1002/1096-9098(200008)74:4<267::AID-JSO5>3.0.CO;2-N

피인용 문헌

  1. Brain metastasis in breast cancer: a comprehensive literature review vol.127, pp.3, 2012, https://doi.org/10.1007/s11060-016-2075-3
  2. Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients vol.49, pp.3, 2012, https://doi.org/10.4143/crt.2016.303
  3. A Rare Case of Docetaxel-Induced Hydrocephalus Presenting with Gait Disturbances Mimicking and Coexisting with Taxane-Associated Polyneuropathy: The Relevance of Differential Diagnosis, Clinical Asses vol.10, pp.3, 2012, https://doi.org/10.1159/000481706
  4. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery vol.136, pp.2, 2018, https://doi.org/10.1007/s11060-017-2666-7
  5. Dural and Leptomeningeal Spine Metastases of Breast Cancer vol.2019, pp.None, 2012, https://doi.org/10.1155/2019/4289362
  6. Propensity for different vascular distributions and cerebral edema of intraparenchymal brain metastases from different primary cancers vol.143, pp.1, 2012, https://doi.org/10.1007/s11060-019-03142-x
  7. Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases vol.2, pp.1, 2012, https://doi.org/10.1093/noajnl/vdaa052
  8. Sector Irradiation vs. Whole Brain Irradiation After Resection of Singular Brain Metastasis—A Prospective Randomized Monocentric Trial vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.591884
  9. Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis vol.10, pp.None, 2012, https://doi.org/10.7573/dic.2021-6-6
  10. Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study vol.13, pp.18, 2021, https://doi.org/10.3390/cancers13184711
  11. Epidemiology of brain metastases and leptomeningeal disease vol.23, pp.9, 2012, https://doi.org/10.1093/neuonc/noab101
  12. Autocrine GMCSF Signaling Contributes to Growth of HER2+ Breast Leptomeningeal Carcinomatosis vol.81, pp.18, 2012, https://doi.org/10.1158/0008-5472.can-21-0259